• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定肝细胞癌总生存期预测的铁死亡相关基因。

Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma.

机构信息

The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, 524023, Guangdong, China.

Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, 524023, Guangdong, China.

出版信息

Sci Rep. 2022 Jun 15;12(1):10007. doi: 10.1038/s41598-022-14554-7.

DOI:10.1038/s41598-022-14554-7
PMID:35705729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9200861/
Abstract

Ferroptosis is a novel type of cell death depending on iron and is strongly related to the development of tumors. Hepatocellular carcinoma (HCC) is a malignancy with high incidence. Despite some reports demonstrating the relation between ferroptosis-related genes and HCC, more details have not been excavated. In the present study, we collected and analyzed HCC patients' datasets from the TCGA-LIHC project and ICGC portal, respectively. Through the bioinformatic methods, we screened 126 differentially expressed genes. Then a prognostic model was established with four genes (GPX2, MT3, PRDX1, and SRXN1). PRDX1 is the hub gene of the prognosis model and has a high expression in hepatocellular carcinoma tumor tissue and cell lines. We further found that silencing PRDX1 increased the accumulation of ferrous ions and lipid peroxidation accumulation in HEPG2 cells and promoted ferroptosis in hepatocellular carcinoma. In conclusion, the study demonstrated the four-gene signature can be used to predict HCC prognosis. It also revealed the potential function of the ferroptosis-related gene PRDX1 in HCC, which can be a biomarker of the prediction for HCC outcome.

摘要

铁死亡是一种新型的依赖于铁的细胞死亡方式,与肿瘤的发生发展密切相关。肝细胞癌(HCC)是一种发病率较高的恶性肿瘤。尽管有一些报道表明铁死亡相关基因与 HCC 之间存在关系,但尚未挖掘出更多细节。在本研究中,我们分别从 TCGA-LIHC 项目和 ICGC 门户中收集和分析了 HCC 患者的数据集。通过生物信息学方法,我们筛选出了 126 个差异表达基因。然后,我们使用四个基因(GPX2、MT3、PRDX1 和 SRXN1)建立了一个预后模型。PRDX1 是预后模型的枢纽基因,在肝癌肿瘤组织和细胞系中高表达。我们进一步发现,沉默 PRDX1 会增加 HEPG2 细胞中铁离子的积累和脂质过氧化产物的积累,从而促进肝癌细胞发生铁死亡。总之,该研究表明,四基因特征可用于预测 HCC 的预后。它还揭示了铁死亡相关基因 PRDX1 在 HCC 中的潜在功能,可作为预测 HCC 结局的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/460de75dcd6d/41598_2022_14554_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/d41e081b664b/41598_2022_14554_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/58e28d9acbd3/41598_2022_14554_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/84bc1e8968cc/41598_2022_14554_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/64481dd79a78/41598_2022_14554_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/c3b4b7f43db6/41598_2022_14554_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/56a9c4888f8c/41598_2022_14554_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/d16d4cc98c8f/41598_2022_14554_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/c000af78246c/41598_2022_14554_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/460de75dcd6d/41598_2022_14554_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/d41e081b664b/41598_2022_14554_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/58e28d9acbd3/41598_2022_14554_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/84bc1e8968cc/41598_2022_14554_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/64481dd79a78/41598_2022_14554_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/c3b4b7f43db6/41598_2022_14554_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/56a9c4888f8c/41598_2022_14554_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/d16d4cc98c8f/41598_2022_14554_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/c000af78246c/41598_2022_14554_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46a9/9200861/460de75dcd6d/41598_2022_14554_Fig9_HTML.jpg

相似文献

1
Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma.鉴定肝细胞癌总生存期预测的铁死亡相关基因。
Sci Rep. 2022 Jun 15;12(1):10007. doi: 10.1038/s41598-022-14554-7.
2
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.构建铁死亡相关的九个长链非编码 RNA 标志物用于预测肝细胞癌的预后和免疫反应。
Front Immunol. 2021 Sep 17;12:719175. doi: 10.3389/fimmu.2021.719175. eCollection 2021.
3
Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.鉴定肝细胞癌铁死亡相关分子模型和免疫亚型,以实现个体化治疗。
Cancer Med. 2023 Jan;12(2):2134-2147. doi: 10.1002/cam4.5032. Epub 2022 Jul 16.
4
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.新型铁死亡相关基因签名可预测肝细胞癌患者的总生存期。
Int J Biol Sci. 2020 Jul 6;16(13):2430-2441. doi: 10.7150/ijbs.45050. eCollection 2020.
5
Integrated analysis of ferroptosis-related gene signature for overall survival prediction in Asian patients with hepatocellular carcinoma.基于铁死亡相关基因特征的综合分析预测亚洲肝细胞癌患者的总生存期。
Clin Transl Oncol. 2023 Mar;25(3):721-730. doi: 10.1007/s12094-022-02977-7. Epub 2022 Nov 1.
6
Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.铁死亡和细胞焦亡的联合构建用于预测肝细胞癌的预后分类器和免疫景观、化疗疗效和免疫抑制分子。
BMC Cancer. 2022 Mar 2;22(1):229. doi: 10.1186/s12885-022-09301-0.
7
Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.铁死亡相关长非编码 RNA 特征预测肝细胞癌的预后。
Aging (Albany NY). 2022 May 12;14(9):4069-4084. doi: 10.18632/aging.204073.
8
Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.鉴定铁死亡和耐药相关的枢纽基因,以预测肝细胞癌的预后。
Sci Rep. 2023 May 29;13(1):8681. doi: 10.1038/s41598-023-35796-z.
9
A Novel Ferroptosis-Related Signature for Prediction of Prognosis, Immune Profiles and Drug Sensitivity in Hepatocellular Carcinoma Patients.一种新型铁死亡相关特征可预测肝癌患者的预后、免疫特征和药物敏感性。
Curr Oncol. 2022 Sep 27;29(10):6992-7011. doi: 10.3390/curroncol29100550.
10
Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma.开发和验证四个与铁死亡相关的基因特征,并研究它们与肝癌免疫相关性的关系。
Front Immunol. 2022 Oct 11;13:1028054. doi: 10.3389/fimmu.2022.1028054. eCollection 2022.

引用本文的文献

1
Identification of ferroptosis related genes and subtypes in colorectal cancer.结直肠癌中铁死亡相关基因及亚型的鉴定
Sci Rep. 2025 Jul 2;15(1):22717. doi: 10.1038/s41598-025-08901-7.
2
A new perspective on iron-dependent cell death: PRDX-1-mediated ferroptosis in tumor cells.铁依赖性细胞死亡的新视角:PRDX-1介导的肿瘤细胞铁死亡
Apoptosis. 2025 Jun 9. doi: 10.1007/s10495-025-02129-6.
3
PRDX1 knockdown promotes erastin-induced ferroptosis and impedes diffuse large B-cell lymphoma development by inhibiting the MAPK/ERK pathway.

本文引用的文献

1
Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma.过氧化物还原酶1对纳他霉素引发的肝癌细胞凋亡和保护性自噬至关重要。
Cancer Lett. 2021 Aug 21;521:210-223. doi: 10.1016/j.canlet.2021.08.023.
2
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.调控氧化应激诱导的铁死亡的分子机制及其在肿瘤中的治疗策略。
Oxid Med Cell Longev. 2020 Dec 21;2020:8810785. doi: 10.1155/2020/8810785. eCollection 2020.
3
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer.
PRDX1基因敲低通过抑制MAPK/ERK途径促进埃拉司亭诱导的铁死亡并阻碍弥漫性大B细胞淋巴瘤的发展。
BMC Cancer. 2025 Apr 30;25(1):806. doi: 10.1186/s12885-025-14173-1.
4
Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches.肝铁过载与肝细胞癌:病理生理机制及治疗方法的新见解
Cancers (Basel). 2025 Jan 24;17(3):392. doi: 10.3390/cancers17030392.
5
The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy.Nrf2 信号在铁死亡激活的癌症治疗中的调控和功能。
Acta Pharmacol Sin. 2024 Nov;45(11):2229-2240. doi: 10.1038/s41401-024-01336-2. Epub 2024 Jul 17.
6
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification.肝细胞癌的铜死亡相关分子分类及基因特征与实验验证
Transl Cancer Res. 2024 Mar 31;13(3):1268-1289. doi: 10.21037/tcr-23-1876. Epub 2024 Mar 27.
7
Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation.铁死亡在代谢相关脂肪性肝病中的新作用:重新审视肝脂质过氧化。
EBioMedicine. 2024 Apr;102:105088. doi: 10.1016/j.ebiom.2024.105088. Epub 2024 Mar 26.
8
Immunomodulation of cuproptosis and ferroptosis in liver cancer.肝癌中铜死亡和铁死亡的免疫调节
Cancer Cell Int. 2024 Jan 10;24(1):22. doi: 10.1186/s12935-023-03207-y.
9
Identification of cuproptosis and ferroptosis-related subgroups and development of a signature for predicting prognosis and tumor microenvironment landscape in hepatocellular carcinoma.肝细胞癌中铜死亡和铁死亡相关亚组的鉴定及预测预后和肿瘤微环境格局的特征构建
Transl Cancer Res. 2023 Dec 31;12(12):3327-3345. doi: 10.21037/tcr-23-685. Epub 2023 Dec 27.
10
Expression And Prognostic Role of PRDX1 In Gastrointestinal Cancers.PRDX1在胃肠道癌症中的表达及预后作用
J Cancer. 2023 Sep 11;14(15):2895-2907. doi: 10.7150/jca.86568. eCollection 2023.
核糖核苷酸还原酶M2亚基可抵御铁死亡,是肝癌的一种肿瘤生物标志物。
Cancer Cell Int. 2020 Dec 7;20(1):587. doi: 10.1186/s12935-020-01689-8.
4
KEGG: integrating viruses and cellular organisms.KEGG:整合病毒和细胞生物。
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551. doi: 10.1093/nar/gkaa970.
5
Iron Metabolism in Ferroptosis.铁死亡中的铁代谢
Front Cell Dev Biol. 2020 Oct 7;8:590226. doi: 10.3389/fcell.2020.590226. eCollection 2020.
6
Sulfiredoxin-1 is a promising novel prognostic biomarker for hepatocellular carcinoma.硫氧还蛋白 1 是一种有前途的新型肝细胞癌预后生物标志物。
Cancer Med. 2020 Nov;9(22):8318-8332. doi: 10.1002/cam4.3430. Epub 2020 Sep 21.
7
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.新型铁死亡相关基因签名可预测肝细胞癌患者的总生存期。
Int J Biol Sci. 2020 Jul 6;16(13):2430-2441. doi: 10.7150/ijbs.45050. eCollection 2020.
8
SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.SRXN1 通过调节 ROS/p65/BTG2 信号通路促进肝细胞癌的发生和转移。
J Cell Mol Med. 2020 Sep;24(18):10714-10729. doi: 10.1111/jcmm.15693. Epub 2020 Aug 3.
9
Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms.金诺芬通过不同的机制减轻系统性铁过载并诱导铁死亡。
Signal Transduct Target Ther. 2020 Jul 31;5(1):138. doi: 10.1038/s41392-020-00253-0.
10
Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer.癌症中细胞铁死亡异常及其功能影响的系统分析
iScience. 2020 Jul 24;23(7):101302. doi: 10.1016/j.isci.2020.101302. Epub 2020 Jun 20.